Aim of the study: The aim of the study is to evaluate neuropsychiatric manifestations among patients who survived COVID-19 and compare these symptoms according to the severity of the illness. Methodology: This cross-sectional study was conducted among survivors of COVID-19 and recruited after at least 6 months of acute illness. They have been interviewed in the outpatient department of a Tertiary care Hospital in Karachi between March 2022 to October 2022. Result: Among 304 patients, 176 were from mild disease and the rest were from other categories of COVID-19. The most significant symptom among all groups was anxiety at the time of acute illness and it also has a direct linear correlation with cognitive impairment with a significant p-value among all groups. While comparing with other neurological symptoms including loss of taste and smell, there was no significant correlation was found.

COVID-19, neuropsychiatric manifestations